BLASZYK MICHAEL D
SEC CIK 1371407 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| IBRX | ImmunityBio, Inc. | Dir | 71.9K | $198.0K | — | 1 | 2023-06-05 | 2023-06-05 |
Most active insiders at IBRX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Simon Barry J. | Dir | — | $4.14M |
| 2 | Selecky Christobel | Dir | — | $3.00M |
| 3 | Cohen Cheryl | Dir | — | $1.25M |
| 4 | Sachs David C. | CFO | — | — |
| 5 | Adcock Richard | CEO, Pres, Dir | — | — |
| 6 | CALIFORNIA CAPITAL EQUITY, LLC | 10% | — | — |
| 7 | LAUER REGAN J | CAO | — | — |
| 8 | SOON-SHIONG PATRICK | See remarks, Dir, 10% | — | — |
BLASZYK MICHAEL D made no open-market trades at IBRX in the last 12 months.
Transactions 1
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2023-06-05 | 2023-06-05 | IBRX | ImmunityBio, Inc. | BLASZYK MICHAEL D | Dir | P - Purchase | $2.75 | +71.9K | 71.9K | New | +$198.0K |
Purchase Sale Sale after option exercise All abbreviations